Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-064390
Filing Date
2023-05-25
Accepted
2023-05-25 08:53:33
Documents
1
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2316962-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2316962-4_4seq1.xml 4 3691
  Complete submission text file 0001104659-23-064390.txt   5136
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Renz Justin A (Reporting) CIK: 0001466562 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 23956411